Abstract
Published lead time estimates in breast cancer screening vary from 1 to 7 years and the percentages of overdiagnosis vary from 0 to 75%. The differences are usually explained as random variations. We study how much can be explained by using different definitions and methods.
| Originalsprog | Engelsk |
|---|---|
| Tidsskrift | B J C |
| Vol/bind | 109 |
| Udgave nummer | 7 |
| Sider (fra-til) | 2014-9 |
| Antal sider | 6 |
| ISSN | 0007-0920 |
| DOI | |
| Status | Udgivet - 1 okt. 2013 |
Fingeraftryk
Dyk ned i forskningsemnerne om 'Overestimated lead times in cancer screening has led to substantial underestimation of overdiagnosis'. Sammen danner de et unikt fingeraftryk.Citationsformater
- APA
- Standard
- Harvard
- Vancouver
- Author
- BIBTEX
- RIS